|
|
 |
Questions and Answers
| February 6, 2008 |
Q & A: Anti-Herpes Drug Does Not Reduce Risk of HIV Infection in People with Genital Herpes Virus, Study Finds (see News Release) |
| September 21, 2007 |
Q & A: HVTN 502 and HVTN 503 HIV Vaccine Clinical Trials (See Statement) l En Espanol (PDF) |
| July 25, 2007 |
Q & A: CHER Study - Treating HIV-Infected Infants Early Helps Them Live Longer (see News Release) |
| February 8, 2007 |
Q & A: Large-Scale HIV Vaccine Trial (HVTN 503) Opens in South Africa (see News Release) |
| February 2007 |
Q & A: Avian Influenza Trials |
| November 29, 2006 |
Q & A: NEJM Article on the SMART Study: CD4+ Count-Guided Episodic Antiretroviral Therapy (see News Release) |
| June 29, 2006 |
Q & A: Leadership for the Newly Reorganized NIAID HIV/AIDS Clinical Trials Networks (see News Release) |
| June 29, 2006 |
Q & A: Adult Male Circumcision Trials in Kenya and Uganda (see Statement) |
| May 2, 2006 |
Q & A: The C.W. Bill Young Center for Biodefense and Emerging Infectious Diseases (Building 33) |
| Jan. 18, 2006 |
Q & A: International HIV/AIDS Trial Finds Continuous Antiretroviral Therapy Superior to Episodic Therapy (see News Release) |
|
July 14, 2005 |
Q & A: Center for HIV/AIDS Vaccine Immunology (CHAVI) (see News Release) |
|
April 7, 2005 |
Q & A: The HIVNET 012 Study and the Safety and Effectiveness of Nevirapine in Preventing Mother-to-Infant Transmission of HIV (see Statement) |
|
|
March 17, 2005 |
Q & A: Open Letter in Science Regarding NIH Biodefense Funding |
|
| |
|
|
|